Royan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301Protective Effect Of Low Dose Of Methamphetamine On The Amount Of Extracellular Glutamine In Primary Fetal Human Astrocytes Induced By Amyloid Beta10511125190210.22074/cellj.2022.7917ENBita SoltanianDepartment of Biology, College of Science, Damghan Branch, Islamic Azad University, Damghan, IranMarzieh Dehghan ShasaltanehDepartment of Biology, Faculty of Science, University of Zanjan, Zanjan, IranGholamhossein RiaziLaboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, IranNahid MasoudianDepartment of Biology, College of Science, Damghan Branch, Islamic Azad University, Damghan, IranJournal Article20220425<strong>Objective:</strong> Change in astrocytes is one of the first pathological symptoms of Alzheimer’s disease (AD). Understanding<br />the signaling pathways in astrocytes can be a great help in treating of AD. This study aimed to investigate signaling pathway relations between low dose of methamphetamine (METH), the apoptosis, cell cycle, and glutamine (Gln) pathways in the activated astrocyte.<br /><strong>Materials and Methods:</strong> In this experimental study, the activated astrocyte cells were exposed to a low dose of METH<br />(12.5 µM) which was determined by Thiazolyl blue tetrazolium bromide (MTT) method. The groups were: group 1 cells with Aβ, group 2 cells with METH, group 3 cells with METH after 24 hours of adding Aβ (Aβ+METH, treated group), group 4 cells with Aβ after 24 hours of adding METH (METH+Aβ, prevention group), and group 5 as the control. The Gln was assayed by high-performance liquid chromatography (HPLC), and also the apoptosis, and cell cycle and BAX, BCL-X expression was evaluated.<br /><strong>Results:</strong> The amount of Gln was increased, and the value of late and early apoptosis was reduced in the treatment groups, and necrosis is decreased in the prevention group (group 4 compared to group 1). Moreover, it was revealed through cell cycle analysis that G2 in group 4 was reduced compared to group 1 and the expression of BAX, BAX/ BCL-X, and BCL-X in group 3 and group 4, was decreased and increased, respectively compared to group 1.<br /><strong>Conclusion:</strong> These findings suggest that perhaps a non-toxic dosage of METH (low dose) can reduce the amount of apoptosis and BAX expression and increase the expression of BCL-X. Furthermore, the cells are arrested in the G2 phase and can raise the amount of extracellular glutamine, which has a protective role in neuron cells. These findings<br />may provide a new perspective to design a new drug with less toxic results. https://www.celljournal.org/article_251902_2bdb9c8492ddfd37a85db926ef2b21be.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301MiR-205 Reverses MDR-1 Mediated Doxorubicin Resistance Via PTEN In Human Liver Cancer HepG2 Cells11211925190410.22074/cellj.2022.7231ENMei LiDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaZhubin LiDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaJuanrong SongDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaXu LiDepartment of Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaPengtao ZhaiDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaXudong MuDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaFakai QiuDepartment of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, ChinaLe YaoDepartment of Infectious Diseases, The First Hospital of Yulin, Yulin, Shaanxi, ChinaJournal Article20220425<strong>Objective: </strong>The aim of the recent study was to investigate the effects of miR-205 on reversing Doxorubicin (DOX) resistance, as chemotherapeutic agents through up-regulation of PTEN in human liver cancer HepG2 cells.<br /><strong>Materials and Methods:</strong> In this experimental study, the drug resistance in liver cancer cells via drug efflux inhibition and enhancing apoptosis by the regulation of PTEN and multi-drug resistance/ P-glycoprotein (MDR/P-gp) expression was revealed. Using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, effect of DOX on cell proliferation was evaluated after miR-205 transfection in HepG2 and HepG2/DOX cells. Activity of P-gp on drug efflux was measured by the Rhodamine 123 (Rho-123) assay. PTEN mRNA expression levels were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and flow cytometry was used to measure the apoptotic ratio of HepG2/DOX cells.<br /><strong>Results:</strong> miR-205 overexpression considerably inhibited the HepG2/DOX cells viability (P<0.05). qRT-PCR results revealed that PTEN is a pivotal regulator in PI3K/Akt/P-gp axis. Overexpression miR-205 resulted in up-regulation PTEN and ultimately down-regulation of P-gp. This inhibits drug resistance, proliferation and induces apoptosis in HepG2/DOX cells (P<0.05). Whilst, treatment with 10 μM of special inhibitors, including LY294002 (PI3K) or PD098059 (MAPK), increased Rho 123-associated MFI, treatment with 10 μM of SF1670 (PTEN) almost abolished the effect of miR-205 overexpression (P<0.05). Finally, we found that miR-205 was down-regulated in HepG2/DOX cells, and its overexpression led to enhancing apoptosis with re-sensitization of HepG2/DOX cell lines to DOX through PTEN/PI3K/ Akt/MDR1 pathway.<br /><strong>Conclusion:</strong> These findings may introduce miR-205 as a predictive biomarker and a potential treatment target for liver cancer therapy during MDR. https://www.celljournal.org/article_251904_71939c68d65677d922bdd97ea893d3a4.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301Mouse Degenerating Optic Axons Survived By Human Embryonic Stem Cell-Derived Neural Progenitor Cells12012625190510.22074/cellj.2022.7873ENShiva NematiDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranZahra SeiedrazizadehDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranSusan SimorghDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranMahdi HesarakiDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, Iran0000-0001-7082-2446Sahar KianiDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranMohammad JavanDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranFarzad PakdelOphthalmic Research Center, Tehran University of Medical Sciences, Tehran, IranLeila SatarianDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranJournal Article20220425<strong>Objective:</strong> Any damage to the optic nerve can potentially lead to degeneration of non-regenerating axons and ultimately<br />death of retinal ganglion cells (RGCs) that in most cases, are not curable by surgery or medication. Neuroprotective functions of different types of stem cells in the nervous system have been evaluated in many studies investigating the effectiveness of these cells in various retinal disease models. Neural progenitor cells (NPCs) secrete an assortment of trophic factors that are vital to the protection of the visual system. We aimed to assess the therapeutic potentials of NPCs in an ONC mouse model.<br /><strong>Materials and Methods: </strong>In this experimental study, NPCs were produced using noggin and retinoic acid from human embryonic stem cells (hESCs). Fifty mice were divided into the following three groups: i. Intact, ii. Vehicle [optic nerve crush+Hank’s balanced salt solution (HBSS)], and iii. Treatment (optic nerve crush+NPCs). The visual behavior of the mice was examined using the Visual Cliff test, and in terms of RGC numbers, they were assessed by Brn3a immunostaining and retrograde tracing using DiI injection.<br /><strong>Results: </strong>Intravenous injection of 50,000 NPCs through visual cliff did not produce any visual improvement. However, our data suggest that the RGCs protection was more than two-times in NPCs compared to the vehicle group as examined by Brn3a staining and retrograde tracing.<br /><strong>Conclusion: </strong>Our study indicated that intravenous injection of NPCs could protect RGCs probably mediated by trophic factors. Due to this ability and good manufacturing practices (GMP) grade production feasibility, NPCs may be used for optic nerve protection.https://www.celljournal.org/article_251905_99dd2a5ad1df284afc7e64ffb918c5c8.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301Characterization Of The Retinal Progenitor Cells Generated Using Co-Culture Systems12713225190610.22074/cellj.2022.7764ENSara MomenzadehHigher Education Jahad University of Isfahan Province, Isfahan, IranFereshteh KaramaliDepartment of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, IranAtefeh AtefDepartment of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, IranMohammad Hossein Nasr EsfahaniDepartment of Cell and Molecular Biology, Cell Sciences Research Center, Royan Institute for Animal Biotechnology,
ACECR, Isfahan, Iran0000-0003-1983-3435Journal Article20220425<strong>Objective: </strong>Degeneration of the photoreceptors due to retinal disorders can affect vision, and even lead to blindness. Recently therapeutic progress in retinal degeneration, using human embryonic stem cells (hESCs), has been facing technical challenges, demanding the development of simple and standardized protocols. In addition to the designing of the protocols, characterization of the obtained cells is highly required for confirming the reliability of the applied methods for future medical applications. Previously, we showed that human stem cells from apical papilla (SCAP) have stromal cell-derived inducing activity (SDIA).<br /><strong>Materials and Methods:</strong> In this experimental study, we developed an efficient retinal differentiation protocol, based on the co-culture of confluent hESCs and SCAP in the absence of exogenous molecules, such as activators or inhibitors of molecular signaling pathways. This experimental procedure resulted in the generation of self-forming neural retina (NR)-like structures containing retinal progenitor cells (RPCs) within 4 weeks.<br /><strong>Results:</strong> We have focused on the characterization of the derived RPCs, as a crucial step towards further verification of the efficiency of our previously suggested protocol. The differentiated cells expressed eye-field markers, PAX6, RAX, LHX2, and SIX3, and also generated neurospheres by a floating culture system for one week.<br /><strong>Conclusion:</strong> We have reported that the treatment of hESC-derived RPCs by the Notch pathway-inhibitor induced the generation of photoreceptor precursor cells (PPCs). The presented method demonstrates the fact that a co-culture of hESCs and SCAP without exogenous molecules provides an efficient approach to produce RPCs for the treatment of retinal disease, and act as an in vitro model for the development of human retina.https://www.celljournal.org/article_251906_cbdbbc240c59982d67299e6414e5763f.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301Generation Of An Induced Pluripotent Stem Cell Line From Human Liver Fibroblasts From A Patient With Combined Hepatocellular-Cholangiocarcinoma13313925190810.22074/cellj.2022.7765ENHyo-Suk AhnStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaJae-Sung RyuStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaJaeseo LeeStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaSeon Ju MunStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaYeon-Hwa HongStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaYongbo ShinStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaKyung-Sook ChungDepartment of Functional Genomics, Korea University of Science and Technology (UST), 217 Gajungro, Yuseong-gu, Daejeon, Republic of KoreaMyung Jin SonStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro,
Yuseong-gu, Daejeon, Republic of KoreaJournal Article20220425<strong>Objective: </strong>Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer with characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The pathogenesis of cHCCCC is poorly understood due to a shortage of suitable in vitro models. Due to scarce availability of human liver tissue, induced pluripotent stem cells (iPSCs) are a useful alternative source to produce renewable liver cells. For use in the development of liver pathology models, here we successfully developed and evaluated iPSCs from liver fibroblasts of a patient with cHCC-CC.<br /><strong>Materials and Methods:</strong> In this experimental study, human liver fibroblasts (HLFs) were obtained from the liver biopsy of<br />a 69-year-old male patient with cHCC-CC and transduced with a retroviral cocktail that included four factors - OCT4, SOX2, KLF4, and c-MYC (OSKM). Pluripotency of the iPSCs was determined by alkaline phosphatase (AP) staining, quantitative real-time polymerase chain reaction (PCR), and immunofluorescence. We induced in vitro embryoid body (EB) formation and performed an in vivo teratoma assay to confirm their differentiation capacity into the three germ layers.<br /><strong>Results: </strong>HLF iPSCs derived from the cHCC-CC patient displayed typical iPSC-like morphology and pluripotency marker expression. The proficiency of the iPSCs to differentiate into three germ layers was assessed both in vitro and in vivo. Compared to normal control iPSCs, differentiated HLF iPSCs showed increased expressions of HCC markers alpha-fetoprotein (AFP) and Dickkopf-1 (DKK1) and the CC marker cytokeratin 7 (CK7), and a decreased expression of the CC tumour suppressor SRY-related HMG-box 17 (SOX17).<br /><strong>Conclusion:</strong> We established HLF iPSCs using liver fibroblasts from a patient with cHCC-CC for the first time. The HLF iPSCs maintained marker expression in the patient when differentiated into EBs. Therefore, HLF iPSCs may be a sustainable cell source for modelling cHCC-CC and beneficial for understanding liver cancer pathology and developing therapies for cHCC-CC treatment. https://www.celljournal.org/article_251908_a3f81b682f87c2167df11541e89d6129.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301LINC00174 Suppresses Non-Small Cell Lung Cancer Progression By Up-Regulating LATS2 Via Sponging MiR-31-5p14014725191110.22074/cellj.2022.7991ENXueling ChengDepartment of Operation, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, ChinaMali ShaDepartment of Thoracic Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, ChinaWenjin JiangDepartment of Interventional Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, ChinaLinjing ChenDepartment of Operation, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, ChinaMeihua SongDepartment of Thoracic Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, ChinaJournal Article20220425<strong>Objective:</strong> Dysregulation of long non-coding RNAs (lncRNAs) is associated with the progression of non-small cell lung cancer (NSCLC). This study aimed to investigate the role of long intergenic non-protein coding RNA 174 (LINC00174)<br />in NSCLC.<br /><strong>Materials and Methods:</strong> In this experimental study, LINC00174 expression in NSCLC tissues and cell lines was investigated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Besides, cell counting kit-8 (CCK8), 5-bromo-2'-deoxyuridine (BrdU). Transwell and Flow Cytometry assays were applied to detect the regulatory function of LINC00174 on the growth, migration and apoptosis of NSCLC cells. Bioinformatics analysis, dual luciferase<br />reporter gene assay and RNA immunoprecipitation (RIP) assay predicted and verified the targeting relationship between<br />LINC00174 and miR-31-5p, and between miR-31-5p and the 3´-untranslated region (3´UTR) of large tumor suppressor kinase 2 (LATS2), respectively. Western blotting was performed to detect the regulatory function of LINC00174 and miR-31-5p on LATS2 protein expression.<br /><strong>Results:</strong> Compared with that in normal lung tissues, LINC00174 expression in NSCLC tissues and cell lines was reduced. LINC00174 expression was negatively associated with the TNM stage of the patients. Functional experiments showed that LINC00174 overexpression inhibited NSCLC cell multiplication and migration, and induced apoptosis. Furthermore, LINC00174 targeted miR-31-5p and repressed its expression. Additionally, LINC00174 upregulated LATS2 expression through competitively binding to miR-31-5p.<br /><strong>Conclusion: </strong>LINC00174, as a competitive endogenous RNA, elevates LATS2 expression by adsorbing miR-31-5p,<br />thereby inhibiting the viability and migration of NSCLC cells, and promoting apoptosis.https://www.celljournal.org/article_251911_a8a71592f4270de9081df5e8a87ba4e5.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301Hypothyroidism And Fertility: An Animal Model Follows Up In The Second-Generation14815425191210.22074/cellj.2022.8054ENFaezeh PanahandehDepartment of Anatomy, Embryology and Histology, Faculty of Medicine, Babol University of Medical Sciences, Babol, IranFarideh FeiziDepartment of Anatomy, Embryology and Histology, Faculty of Medicine, Babol University of Medical Sciences, Babol, IranMohsen PourghasemDepartment of Anatomy, Embryology and Histology, Faculty of Medicine, Babol University of Medical Sciences, Babol, IranSorya KhafriDepartment of Epidemiology and Biostatistics, School of Public Health, Infertility and Reproductive Health Research Center, Health
Research Institute, Babol University of Medical Sciences, Babol, IranZeinab AbedianCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IranKaveh PourghasemDepartment of Medical Sciences, Macquarie University, Sydney, NSW, AustraliaZohre EsmaeiliDepartment of Anatomy, Embryology and Histology, Faculty of Medicine, Babol University of Medical Sciences, Babol, IranJournal Article20220425<strong>Objective:</strong> Hypothyroidism is known as the most common endocrine disorder. The prevalence of hypothyroidism in the female and male population is 2% and 0.2%, respectively. Maternal hypothyroidism is a defect in the thyroid hormones transition from the mother to the fetus. The present study was conducted to find whether maternal hypothyroidism affects the fertility of the second generation.<br /><strong>Materials and Methods:</strong> In this experimental study, twelve adult female rats weighting 180-220 g were randomly divided into case and control groups. Hypothyroidism was induced by dissolving 0.1 g/L of 6-n-propyl-2-thiouracil in drinking water toward the end of pregnancy and lactation. At the end of the breastfeeding period, the blood samples of female children were collected. Six healthy, mature, female rats were selected and kept until they reached maturity, and were then mated with male rats. After observing the female rats’ delivery, blood samples were collected from their male and female newborns and the healthy rats were selected.<br /><strong>Results: </strong>There was a significant difference in the volume and size of ovarian as well as in the number of secondary<br />follicles in comparison with the control group (P=0.025). However, there were no significant changes in the other parameters including the number of primary follicles, the number of Graafian follicles and sperm parameters. There was no significant decrease in the testicular volume and size, number of Leydig cells and seminiferous tubules diameter.<br /><strong>Conclusion:</strong> Maternal hypothyroidism has no significant effects on testicular tissue function, and sperm parameters in<br />the second generation, but can significantly reduce the rate of secondary follicles in the second generation female rats.https://www.celljournal.org/article_251912_2d0d065e320f8d38f0afa5e9c297ae74.pdfRoyan Institute, Iranian Academic Center for Education Culture and Research (ACECR)Cell Journal (Yakhteh)2228-580624320220301The Impact Of Different Cell Culture Mediums On CD8+T Cells Expansion: A Bioinformatics Study15516225191410.22074/cellj.2022.7779ENArsalan JaliliDepartment of Applied Cell Sciences, Faculty of Basic Sciences and Advanced Medical Technologies, Royan Institute, ACECR, Tehran,
IranAbbas HajifathaliHematopoeitic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranAhmad BereimipourDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and
Technology, ACECR, Tehran, IranElham RoshandelHematopoeitic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranNasser AghdamiDepartment of Regenerative Biomedicine and Cell Terapy, Royan Institute for Stem Cell Biology and Technology,
ACECR, Tehran, Iran0000-0002-0562-9567Journal Article20220425<strong>Objective:</strong> Different Cell Culture medias can affect the expansion of T cells. The aim of this study is to assess signaling<br />pathways, protein interactions and genes in T cells cultured in different common T cell expansion medias to select the<br />best candidate.<br /><strong>Materials and Methods:</strong> In this in silico observational study, with the use of bioinformatics analysis and the use of enrichment databases, gene expression profiles were investigated using microarray analysis.<br /><strong>Results:</strong> The results of this study were the joint selection of 26 upregulated genes and 59 downregulated genes that were involved in SREBP control of lipid synthesis, co-stimulatory signal during T-cell activation mitosis and chromosome<br />dynamics, telomeres, telomerase, and cellular aging signal pathways.<br /><strong>Conclusion: </strong>Using bioinformatics analyzes, integrated and regular genes were selected as common genes CD80, LST1, ATM and ITM2B 4-1BBL, Akt inhibitor, interleukin 7 and 15 expansion media. https://www.celljournal.org/article_251914_c3cec0c91ea8193394ef61a494b272ab.pdf